NCT06428162

Brief Summary

Egypt's several regions-rural, mixed, and urban-were given pre-designed surveys pertaining to drug adverse events and the role of pharmacovigilance in detection and reporting. The three sections of the survey were dedicated to studying health care professionals' knowledge concerning pharmacovigilance concepts and practices, as well as demographics and people reported or not reported. The survey also asked more questions regarding adverse occurrences that were reported.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 18, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 24, 2024

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2024

Completed
Last Updated

August 7, 2024

Status Verified

August 1, 2024

Enrollment Period

3 months

First QC Date

May 20, 2024

Last Update Submit

August 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • reported adverse drug reactions

    collect recent adverse drug reaction reports

    3 months

Interventions

three sections questioner including: demographics, reported cases, unreported cases

Eligibility Criteria

Age25 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

all health care providers that deals with drugs and medications as pharmacists, physicians, Dentists, nurses and medical reps are invited to share in this survey as a hard template. study included 300 subject in different disciplines at the period at 3 months. complete survey composed of 3 sections included previous reported ADVEs

You may qualify if:

  • all health care providers are invited to share in the study
  • minimum experience required is one year in health carrier.
  • accept sharing in the study

You may not qualify if:

  • health care providers who refuse to complete all data required in the survey.
  • fresh experience or participants who left health carrier

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Deraya university

Minya, 05673, Egypt

Location

MeSH Terms

Conditions

Drug-Related Side Effects and Adverse ReactionsDrug HypersensitivitySubstance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor of pharamcy practices, faculaty of pharmacy, Deraya University

Study Record Dates

First Submitted

May 20, 2024

First Posted

May 24, 2024

Study Start

February 18, 2024

Primary Completion

May 20, 2024

Study Completion

June 20, 2024

Last Updated

August 7, 2024

Record last verified: 2024-08

Locations